KL-6 is a glycoprotein made by alveolar type II and bronchial epithelial cells, and it is a biomarker of lung epithelial damage, useful for diagnosing and predicting outcomes in interstitial lung diseases (ILDs), including lung function decline, mortality, and treatment response [7]. The gene discussed is MUC1; the disease is interstitial lung disease.